To summarize the methodology critique of a study identifying three distinct clinical phenotypes among critically ill patients with candidemia using unsupervised machine learning.
Approach:
Macroscopic Level Critique: Questions the clinical utility of the derived clusters, suggesting they merely reflect known clinical realities rather than providing actionable insights.
Microscopic Level Critique: Highlights feature selection bias due to the inclusion of mortality surrogates in the clustering algorithm, which may skew results.
Key Findings:
The identified phenotypes correspond to established clinical categories.
Survival curve differences are influenced by feature selection bias.
Inclusion of SAPS II in the clustering algorithm affects the model's ability to identify true biological signatures.
Interpretation:
The study's findings may not provide new clinical insights due to methodological flaws, particularly the reliance on established severity scores.
Limitations:
Algorithmic tautology at the macroscopic level.
Feature selection bias due to the inclusion of mortality surrogates.
Conclusion:
Future models should exclude clinical scores linked to mortality to identify novel biological endotypes.
